Literature DB >> 31390300

Surveillance, Epidemiology, and Estimated Burden of Neonatal Abstinence Syndrome, Tennessee, 2013-2016.

Julia Brennan1,2, Caleb Wiedeman2, John R Dunn2, William Schaffner3, Timothy F Jones2.   

Abstract

OBJECTIVES: Between 2003 and 2013, the rate of neonatal abstinence syndrome (NAS)-a postnatal drug withdrawal syndrome-in Tennessee increased approximately 10-fold. NAS surveillance is relatively new, and underestimation associated with surveillance has not been described. We compared data from the Tennessee NAS public health surveillance system (TNSS) with a second source of NAS data, hospital discharge data system (HDDS), and estimated the true number of infants with NAS using capture-recapture methods.
METHODS: We obtained NAS data on cases of NAS among Tennessee infants from TNSS and HDDS from January 1, 2013, through December 31, 2016. We matched cases of NAS identified in TNSS to cases identified in HDDS. We estimated the true number of infants with NAS by using the Lincoln-Peterson estimator capture-recapture methodology.
RESULTS: During the study period, 4070 infants with NAS were reported to TNSS, and 5321 infants with NAS were identified in HDDS; 2757 were in both data sets. Using capture-recapture methods, the total estimated number of infants with NAS during the study period was 7855 (annual mean = 1972; estimated range = 1531-2427), which was 93% more than in TNSS and 48% more than in HDDS. Drugs used for the medication-assisted treatment of substance use disorder were the most commonly reported substances associated with NAS (n = 2389, 59%).
CONCLUSIONS: TNSS underestimated the total burden of NAS based on the capture-recapture estimate. Case-based public health surveillance is important for monitoring the burden of and risk factors for NAS and helping guide public health interventions.

Entities:  

Keywords:  MAT; capture-recapture; medication-assisted treatment; neonatal abstinence syndrome; surveillance system

Mesh:

Year:  2019        PMID: 31390300      PMCID: PMC6852066          DOI: 10.1177/0033354919867718

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  20 in total

1.  Neonatal Abstinence Syndrome and High School Performance.

Authors:  Ju Lee Oei; Edward Melhuish; Hannah Uebel; Nadin Azzam; Courtney Breen; Lucinda Burns; Lisa Hilder; Barbara Bajuk; Mohamed E Abdel-Latif; Meredith Ward; John M Feller; Janet Falconer; Sara Clews; John Eastwood; Annie Li; Ian M Wright
Journal:  Pediatrics       Date:  2017-01-16       Impact factor: 7.124

2.  Ascertainment corrected rates: applications of capture-recapture methods.

Authors:  D J McCarty; E S Tull; C S Moy; C K Kwoh; R E LaPorte
Journal:  Int J Epidemiol       Date:  1993-06       Impact factor: 7.196

3.  Male Sex Associated With Increased Risk of Neonatal Abstinence Syndrome.

Authors:  M Katherine Charles; William O Cooper; Lauren M Jansson; Judith Dudley; James C Slaughter; Stephen W Patrick
Journal:  Hosp Pediatr       Date:  2017-05-02

4.  Committee Opinion No. 711: Opioid Use and Opioid Use Disorder in Pregnancy.

Authors: 
Journal:  Obstet Gynecol       Date:  2017-08       Impact factor: 7.661

5.  Adverse neurodevelopmental outcome of infants exposed to opiate in-utero.

Authors:  Rod W Hunt; Dimitra Tzioumi; Edith Collins; Heather E Jeffery
Journal:  Early Hum Dev       Date:  2007-08-28       Impact factor: 2.079

6.  Incidence of Neonatal Abstinence Syndrome - 28 States, 1999-2013.

Authors:  Jean Y Ko; Stephen W Patrick; Van T Tong; Roshni Patel; Jennifer N Lind; Wanda D Barfield
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-08-12       Impact factor: 17.586

7.  Treating women with opioid use disorder during pregnancy in Appalachia: Initial neonatal outcomes following buprenorphine + naloxone exposure.

Authors:  Linda Nguyen; Laura R Lander; Kevin E O'Grady; Patrick J Marshalek; Adrienne Schmidt; Audra K Kelly; Hendrée E Jones
Journal:  Am J Addict       Date:  2018-02-23

Review 8.  Medication-assisted treatment with buprenorphine: assessing the evidence.

Authors:  Cindy Parks Thomas; Catherine Anne Fullerton; Meelee Kim; Leslie Montejano; D Russell Lyman; Richard H Dougherty; Allen S Daniels; Sushmita Shoma Ghose; Miriam E Delphin-Rittmon
Journal:  Psychiatr Serv       Date:  2014-02-01       Impact factor: 3.084

9.  Implementation of a statewide surveillance system for neonatal abstinence syndrome - Tennessee, 2013.

Authors:  Michael D Warren; Angela M Miller; Julie Traylor; Audrey Bauer; Stephen W Patrick
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-02-13       Impact factor: 17.586

10.  Measuring underreporting and under-ascertainment in infectious disease datasets: a comparison of methods.

Authors:  Cheryl L Gibbons; Marie-Josée J Mangen; Dietrich Plass; Arie H Havelaar; Russell John Brooke; Piotr Kramarz; Karen L Peterson; Anke L Stuurman; Alessandro Cassini; Eric M Fèvre; Mirjam E E Kretzschmar
Journal:  BMC Public Health       Date:  2014-02-11       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.